Next |
home / stock / mrsn / mrsn message board
Subject | By | Source | When |
---|---|---|---|
znewcar1: $MRSN 46% v15,6M C6.40 f109,069M H6.71 ML3.68 RL4.27 gapNgo S@6 | znewcar1 | investorshangout | 05/04/2023 3:45:42 AM |
Price trading last up | jaybe | investorshub | 04/30/2023 7:14:44 PM |
$MRSN Price gaining last up | dorothy52 | investorshub | 04/30/2023 1:10:48 PM |
what do you make of this data? | jaybe | investorshub | 04/30/2023 1:01:14 AM |
The now last trade up | TrendTrade2016 | investorshub | 04/29/2023 2:21:40 AM |
best news of the day | ClayTrader | investorshub | 04/28/2023 10:15:00 AM |
The now | ClayTrader | investorshub | 04/24/2023 2:11:00 PM |
$MRSN short data if anyone is interested | bladerunner1717 | investorshub | 04/23/2023 2:06:28 AM |
$MRSN Found an interesting article | bladerunner1717 | investorshub | 04/17/2023 1:52:42 AM |
MomentumIts gaining | MRDALE | investorshub | 04/16/2023 6:34:22 PM |
and the shorts continue | edwardport | investorshub | 04/15/2023 7:26:53 AM |
$MRSN The gaining | TrendTrade2016 | investorshub | 04/13/2023 4:29:52 PM |
$MRSN MomentumIts gaining | edwardport | investorshub | 04/13/2023 2:43:27 PM |
$MRSN Lets go go go go... Up up and away we go. | jaybe | investorshub | 04/12/2023 3:33:20 AM |
MomentumIts now | ClayTrader | investorshub | 04/10/2023 8:51:43 PM |
MomentumIts now | jaybe | investorshub | 04/09/2023 6:18:14 PM |
The now last trade up | jaybe | investorshub | 04/09/2023 10:39:13 AM |
$MRSN must see | jaybe | investorshub | 04/08/2023 9:08:58 AM |
news out | jaybe | investorshub | 04/08/2023 2:54:00 AM |
The now last trade up | ClayTrader | investorshub | 04/03/2023 9:20:36 PM |
News, Short Squeeze, Breakout and More Instantly...
Mersana Therapeutics Inc. Company Name:
MRSN Stock Symbol:
NASDAQ Market:
Mersana Therapeutics Inc. Website:
Maximum tolerated dose not yet established in Phase 1 clinical trial of XMT-1660; enrollment in dose escalation and backfill cohorts continuing in parallel; expect to announce initial clinical data and initiate expansion in the second half of 2024 Patient recruitment ongoing in Phase 1 cl...
CAMBRIDGE, Mass., May 02, 2024 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of high unmet medical need, today announced that ...
2024-03-18 08:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...